Gençer Genç

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

Ana Westenberger, Volha Skrahina, Tatiana Usnich et al. · Brain · 2024 · 89 citations · Full text

Life Sciences, Genetics, Neurology +15

Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease

Hesham Abboud, Darlene Floden, Nicolas R. Thompson et al. · Parkinsonism & Related Disorders · 2014 · 60 citations

Medicine, Neuroscience, Surgery +14

Serum Adiponectin, TNF-α, IL-12p70, and IL-13 Levels in Multiple Sclerosis and the Effects of Different Therapy Regimens

Uğur Muşabak, Şeref Demirkaya, Gençer Genç et al. · NeuroImmunoModulation · 2010 · 55 citations

Life Sciences, Immunology, Pharmacotherapy +17

GC and VDR SNPs and Vitamin D Levels in Parkinson’s Disease: The Relevance to Clinical Features

Duygu Gezen‐Ak, Merve Alaylıoğlu, Gençer Genç et al. · NeuroMolecular Medicine · 2016 · 52 citations

Medicine, Molecular Genetics, Neurology +17

A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD)

Shnehal Patel, Oluwadamilola O. Ojo, Gençer Genç et al. · Journal of Clinical Movement Disorders · 2017 · 51 citations · Full text

Medicine, Neurology, Pharmacotherapy +17